Oxford Centre for Immuno-Oncology, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ GlaxoSmithKline and Oxford University (GO) launched the PRECIsE Alliance (Pre-Cancer Biology and Immunoprevention) in 2025 with the aim of conducting deep exploration of precancers to identify their molecular vulnerabilities and developing methods to intercept them. Within Oxford, the alliance spans multiple departments and networks basic science (including spatial biology, genomics, proteomics, immunopeptidomics), immunology (including machine learning, bioinformatics, preclinical validation) and clinical development (including trial design and delivery and regulatory approval) expertise as well as community engagement. This truly multi-disciplinary initiative seeks to transform cancer by actively preventing it from developing, initially in people at highest risk of the disease and later in the wider population. The applicant will join the T-cell Epitope Discovery Group led by Dr. Eleni Adamopoulou, within the Centre for Immuno-Oncology directed by Professor Timothy Elliott. It is essential that you hold a PhD/DPhil in biology, bioinformatics or related field and have experience of multiple bioinformatic approaches applied to immunology. You will also have experience in developing new bioinformatic pipelines, experience of computational biology as well as coding in multiple languages (R and Python essential). Ability to contribute to determining future directions for the research project, ability to take initiative in developing new bioinformatic approaches, and effective communication skills are essential to the role. Postdoctoral experience in developing bioinformatic pipelines for the discovery of cancer antigens and a deep understanding of mechanistic immunology, with previous research in the field of antigen processing/presentation or mmunopeptidomics are highly desirable.